A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine

Journal of Immunology

Volumn 161, Issue 5, 1998, Pages 2325-2332

  Weiss, Walter R ^a   Ishii, Ken J ^b   Hedstrom, Richard C ^a   Sedegah, Martha ^a,c   Ichino, Motohide ^b   Barnhart, Kerry ^d   Klinman, Dennis M ^b   Hoffman, Stephen L ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b Center for Biologics Evaluation/Res   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d VICAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; MALARIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PLASMID; PLASMODIUM YOELII; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMIDS; PLASMODIUM YOELII; VACCINES, DNA;

EID: 0032167401     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Nussenzweig, R., J. Vanderberg, and H. Most. 1969. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity. Mil. Med. 134:1176.
2. Clyde, D. F., H. Most, V. C. McCarthy, and J. P. Vanderberg. 1973. Immunization of man against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266:169.
3. Rieckmann, K. H., P. E. Carson, R. L. Beaudoin, J. S. Cassells, and K. W. Sell. 1974. Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 68:258.
4. + cells and malaria sporozoites. Immunol. Lett. 25:59.
5. + cytolytic T cell clone confers protection against murine malaria. J. Exp. Med. 172:1353.
6. + T cell- and IFN-γ-dependent elimination of infected hepatocytes. J. Immunol. 157:4061.
7. + T cell clones against Plasmodium yoelii liver stages. J. Immunol. 150:1471.
8. + T cells, and antibodies required for immunity to malaria sporozoites. Nature 330:664.
9. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 85:573.
10. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin-12 induction of interferon-γ-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700.
11. + T cell, interferon-γ, and nitric oxide dependent immunity. J. Exp. Med. 183:1739.
12. + T cells surrounding Plasmodium berghei-infected hepatocytes. Infect. Immun. 65:3882.
13. + T cells. J. Exp. Med. 180:353.
14. Weiss, W. R., S. Mellouk, R. A. Houghten, M. Sedegah, S. Kumar, M. F. Good, J. A. Berzofsky, L. H. Miller, and S. L. Hoffman. 1990. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med. 171:763.
15. Charoenvit, Y., S. Mellouk, C. Cole, R. Bechara, M. F. Leef, M. Sedegah, L. F. Yuan, F. A. Robey, R. L. Beaudoin, and S. L. Hoffman. 1991. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. J. Immunol. 146:1020.
16. Lal, A. A., V. F. De La Cruz, J. A. Welsh, Y. Charoenvit, W. L. Maloy, and T. F. McCutchan. 1987. Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. J. Biol. Chem. 262:2937.
17. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866.
18. Metcalf, D. 1985. The granulocyte-macrophage colony-stimulating factors. Science 229:16.
19. Tarr, P. E. 1996. Granulocyte-macrophage colony-stimulating factor and the immune system. Med. Oncol. 13:133.
20. Tarr, P. E., R. Lin, E. A. Mueller, J. M. Kovarik, M. Guillaume, and T. C. Jones. 1996. Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine. Vaccine 14:1199.
21. Xiang, Z., and H. C. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129.
22. Kim, J. J., V. Ayyavoo, M. L. Bagarazzi, M. A. Chattergoon, K. Dang, B. Wang, J. D. Boyer, and D. B. Weiner. 1997. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:816.
23. Iwasaki, A., B. J. Stiernholm, A. K. Chan, N. L. Berinstein, and B. H. Barber. 1997. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158:4191.
24. Geissler, M., A. Gesien, K. Tokushige, and J. R. Wands. 1997. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158:1231.
25. Okada, E., S. Sasaki, N. Ishii, I. Aoki, T. Yasuda, K. Nishioka, J. Fukushima, J. I. Miyazaki, B. Wahren, and K. Okuda. 1997. Intranasal immunization of a DNA vaccine with IL-12 and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:3638.
26. Hartikka, J., M. Sawdey, F. Comefert Jensen, M. Margalith, K. Barnhart, M. Nolasco, H. L. Vahlsing, J. Meek, M. Marquet, P. Hobart, J. Norman, and M. Manthorpe. 1996. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum. Gene Ther. 7:1205.
27. Charoenvit, Y., M. L. Leef, L. F. Yuan, M. Sedegah, and R. L. Beaudoin. 1987. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect. Immun. 55:604.
28. Cullen, B. R. 1988. Expression of a cloned human interleukin-2 cDNA is enhanced by the substitution of a heterologous mRNA leader region. DNA 7:645.
29. Meropol, N. J., S. W. Altmann, A. B. Shanafelt, R. A. Kastelein, G. D. Johnson, and M. B. Prystowsky. 1992. Requirement of hydrophilic amino-terminal residues for granulocyte-macrophage colony-stimulating factor bioactivity and receptor binding. J. Biol. Chem. 267:14266.
30. Meropol, N. J., B. L. Kreider, V. M. Lee, K. Kaushansky, and M. B. Prystowsky. 1991. A neutralizing monoclonal antibody binds to an epitope near the amino terminus of murine granulocyte-macrophage colony-stimulating factor. Hybridoma 10:433.
31. Luke, C. J., K. Carner, X. Liang, and A. G. Barbour. 1997. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J. Infect. Dis. 175:91.
32. Nakoinz, I., M. T. Lee, J. F. Weaver, and P. Ralph. 1990. Differentiation of the IL-3-dependent NFS-60 cell line and adaption to growth in macrophage colony-stimulating factor. J. Immunol. 145:860.
33. + T cells using an ELISPOT assay. J. Immunol. Methods 181:45.
34. Mor, G., D. M. Klinman, S. Shapiro, E. Hagiwara, M. Sedegah, J. A. Norman, S. L. Hoffman, and A. D. Steinberg. 1995. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J. Immunol. 155:2039.
35. Shirai, A., V. Sierra, C. I. Kelly, and D. M. Klinman. 1994. Individual cells simultaneously produce both IL-4 and IL-6 in vivo. Cytokine 6:329.
36. Klinman, D. M. 1994. ELISPOT assay to detect cytokine-secreting murine and human cells. In Current Protocols in Immunology. J. E. Coligan, ed. Wiley, New York, p. 19.1.
37. Shirai, A., J. Conover, and D. M. Klinman. 1995. Increased activation and altered ratio of interferon-γ: interleukin-4 secreting cells in MRL-lpr/lpr mice. Autoimmunity 21:107.
38. Klinman, D. M., A. K. Yi, S. L. Beaucage, J. Conover, and A. M. Krieg. 1996. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon-γ. Proc. Natl. Acad. Sci. USA 93:2879.
39. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546.
40. Yi, A. K., D. M. Klinman, T. L. Martin, S. Matson, and A. M. Krieg. 1996. Rapid immune activation by CpG motifs in bacterial DNA: systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157:5394.
41. Klinman, D. M., G. Yamshchikov, and Y. Ishigatsubo. 1997. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:3635.
42. Weiss, W. R., M. F. Good, M. R. Hollingdale, L. H. Miller, and J. A. Berzofsky. 1989. Genetic control of immunity to Plasmodium yoelii sporozoites. J. Immunol. 143:4263.
43. Doe, B., M. Selby, S. Barnett, J. Baenziger, and C. M. Walker. 1996. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93:8578.
44. Corr, M., D. J. Lee, D. A. Carson, and H. Tighe. 1996. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1555.
45. Iwasaki, A., C. A. Torres, P. S. Ohashi, H. L. Robinson, and B. H. Barber. 1997. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159:11.
46. Lieschke, G. J., and A. W. Burgess. 1992. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). N. Engl. J. Med. 327: 99.
47. Kurzrock, R., M. Talpaz, and J. U. Gutterman. 1992. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia. Am. J. Med. 93:41.
48. Estey, E. H., R. Kurzrock, M. Talpaz, K. B. McCredie, S. O'Brien, H. M. Kantarjian, M. J. Keating, A. B. Deisseroth, and J. U. Gutterman. 1991. Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes. Br. J. Haematol. 77:291.
49. Simons, J. W., E. M. Jaffee, C. E. Weber, H. I. Levitsky, W. G. Nelson, M. A. Carducci, A. J. Lazenby, L. K. Cohen, C. C. Finn, S. M. Clift, K. M. Hauda, L. A. Beck, K. M. Leiferman, A. H. Owens, Jr., S. Piantadosi, G. Dranoff, R. C. Mulligan, D. M. Pardoll, and F. F. Marshall. 1997. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res. 57:1537.